IL90731A - Vibrant pharmaceutical preparations for oral use containing ranitidine or its salt - Google Patents

Vibrant pharmaceutical preparations for oral use containing ranitidine or its salt

Info

Publication number
IL90731A
IL90731A IL9073189A IL9073189A IL90731A IL 90731 A IL90731 A IL 90731A IL 9073189 A IL9073189 A IL 9073189A IL 9073189 A IL9073189 A IL 9073189A IL 90731 A IL90731 A IL 90731A
Authority
IL
Israel
Prior art keywords
pharmaceutical composition
ranitidine
unit dose
citrate
free base
Prior art date
Application number
IL9073189A
Other languages
English (en)
Hebrew (he)
Other versions
IL90731A0 (en
Original Assignee
Glaxo Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Sa filed Critical Glaxo Lab Sa
Publication of IL90731A0 publication Critical patent/IL90731A0/xx
Publication of IL90731A publication Critical patent/IL90731A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL9073189A 1988-06-24 1989-06-23 Vibrant pharmaceutical preparations for oral use containing ranitidine or its salt IL90731A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8808497A FR2633181B1 (fr) 1988-06-24 1988-06-24 Composition pharmaceutique a base de ranitidine et son procede de preparation

Publications (2)

Publication Number Publication Date
IL90731A0 IL90731A0 (en) 1990-01-18
IL90731A true IL90731A (en) 1994-04-12

Family

ID=9367671

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9073189A IL90731A (en) 1988-06-24 1989-06-23 Vibrant pharmaceutical preparations for oral use containing ranitidine or its salt

Country Status (32)

Country Link
US (1) US5102665A (no)
JP (1) JPH0786086B2 (no)
KR (1) KR940002662B1 (no)
AT (1) AT396426B (no)
AU (1) AU627194B2 (no)
BE (1) BE1005691A4 (no)
CA (1) CA1329130C (no)
CH (1) CH679276A5 (no)
CY (1) CY1637A (no)
CZ (1) CZ280886B6 (no)
DE (1) DE3920626C2 (no)
DK (1) DK170223B1 (no)
ES (1) ES2015717A6 (no)
FR (1) FR2633181B1 (no)
GB (1) GB2219940B (no)
HK (1) HK33192A (no)
HU (1) HU210067A9 (no)
IE (1) IE60725B1 (no)
IL (1) IL90731A (no)
IT (1) IT1232149B (no)
LU (1) LU87541A1 (no)
MY (1) MY106412A (no)
NL (1) NL8901596A (no)
NZ (1) NZ229698A (no)
PH (1) PH26018A (no)
PT (1) PT90962B (no)
SA (1) SA90100095B1 (no)
SE (1) SE502285C2 (no)
SG (1) SG21892G (no)
SK (1) SK278823B6 (no)
ZA (1) ZA894787B (no)
ZW (1) ZW7889A1 (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ230701A (en) * 1988-09-20 1992-01-29 Glaxo Group Ltd Pharmaceutical compositions comprising ranitidine, alginic acid and a carbonate or bicarbonate
DE4027927A1 (de) * 1990-09-04 1992-03-05 Bayer Ag Brausekomponente und verfahren zu ihrer herstellung
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
CA2055661A1 (en) * 1990-12-21 1992-06-22 Manley A. Paulos Treatment of upset stomach associated with heartburn, sour stomach or acid indigestion with an effervescent h2 blocker formulation
US5629013A (en) * 1991-04-04 1997-05-13 The Procter & Gamble Company Chewable calcium carbonate antacid tablet compositions
FR2700669B1 (fr) * 1993-01-22 1995-04-14 Tassoni Jean Pierre Composition effervescente pour la préparation de boissons gazeuses.
US5503846A (en) * 1993-03-17 1996-04-02 Cima Labs, Inc. Base coated acid particles and effervescent formulation incorporating same
US5407687A (en) * 1994-02-22 1995-04-18 Glaxo Inc. Ranitidine solid dosage form
IL112779A (en) * 1994-03-01 1999-11-30 Gergely Gerhard Granular product or tablet containing an efferescent system and an active pharmaceutical substance and its preparation
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
SE512835C2 (sv) * 1996-01-08 2000-05-22 Astrazeneca Ab Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare
JP2000511178A (ja) * 1996-05-17 2000-08-29 メルク エンド カンパニー インコーポレーテッド 発泡性ビスホスホネート製剤
US5728401A (en) * 1997-04-16 1998-03-17 Ranbaxy Laboratories, Ltd. Effervescent ranitidine formulations
HUP9701293A3 (en) * 1997-07-25 1999-08-30 Chinoin Gyogyszer Es Vegyeszet New salts without unsavoury taste and pharmaceutical compositions containing them
US20030091629A1 (en) * 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
US6974590B2 (en) * 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
US6264984B1 (en) 1999-12-06 2001-07-24 Bristol-Myers Squibb Company Effervescent histamine H2 antagonist composition
JP2001253826A (ja) * 2000-03-09 2001-09-18 Maruzen Pharmaceut Co Ltd 内服用剤
JP4346311B2 (ja) * 2001-04-27 2009-10-21 京都薬品工業株式会社 発泡性坐剤の保存方法
US20030104017A1 (en) * 2001-10-26 2003-06-05 Boehringer Ingelheim International Gmbh Epinastine formulation for oral administration
EP1558211A2 (en) * 2002-10-30 2005-08-03 Pharmacia Corporation Oral extended release tablets and methods of making and using the same
US20050089502A1 (en) * 2003-08-21 2005-04-28 Todd Schansberg Effervescent delivery system
WO2005065317A2 (en) * 2003-12-31 2005-07-21 Cima Labs Inc. Effervescent oral fentanyl dosage form
JP5244318B2 (ja) * 2003-12-31 2013-07-24 シーマ・ラブス、インコーポレイテッド 発泡性経口アヘン薬投薬形態およびアヘン薬の投与方法
EA010826B1 (ru) * 2003-12-31 2008-12-30 Сайма Лэбс Инк. Лекарственная форма фентанила для перорального применения, способ ее получения и способы лечения
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
AU2005247048B2 (en) * 2004-05-28 2007-12-13 Imaginot Pty Ltd Oral therapeutic compound delivery system
US20060100271A1 (en) * 2004-11-08 2006-05-11 Keith Whitehead Stabilized aqueous ranitidine compositions
AU2006317530B2 (en) * 2005-11-28 2011-09-01 Imaginot Pty Ltd Oral therapeutic compound delivery system
WO2009008895A1 (en) * 2007-07-09 2009-01-15 Cypress Pharmaceutical, Inc. Pleasant-tasting ranitidine formulation
KR20170003414A (ko) * 2015-06-30 2017-01-09 (주)아모레퍼시픽 속붕해형 과립환 모발 세정용 조성물
CN105997922A (zh) * 2016-06-12 2016-10-12 佛山市腾瑞医药科技有限公司 一种盐酸雷尼替丁泡腾片及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1962791A1 (de) * 1969-12-15 1971-06-24 Boehringer Mannheim Gmbh Brausetabletten,Brausepulver und Verfahren zur Herstellung derselben
GB8313217D0 (en) * 1983-05-13 1983-06-22 Glaxo Group Ltd Pharmaceutical compositions
NZ215069A (en) * 1985-03-01 1988-06-30 Reckitt & Colmann Prod Ltd Pharmaceutical composition with histamine h 2 -receptor antagonist
FR2593065B1 (fr) * 1986-01-22 1988-09-09 Smith Kline French Lab Couples effervescents, compositions effervescentes d'antagonistes h2 de l'histamine les contenant et leur preparation.
GB8909793D0 (en) * 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation

Also Published As

Publication number Publication date
GB8914428D0 (en) 1989-08-09
ATA154489A (de) 1993-01-15
ES2015717A6 (es) 1990-09-01
HU210067A9 (en) 1995-02-28
MY106412A (en) 1995-05-30
NL8901596A (nl) 1990-01-16
US5102665A (en) 1992-04-07
KR940002662B1 (ko) 1994-03-28
ZW7889A1 (en) 1990-02-21
JPH0245421A (ja) 1990-02-15
SG21892G (en) 1992-04-16
ZA894787B (en) 1990-03-28
PT90962B (pt) 1994-12-30
SK403891A3 (en) 1998-03-04
IT1232149B (it) 1992-01-25
AU627194B2 (en) 1992-08-20
DK170223B1 (da) 1995-07-03
SE8902288D0 (sv) 1989-06-22
JPH0786086B2 (ja) 1995-09-20
DK314089D0 (da) 1989-06-23
FR2633181A1 (fr) 1989-12-29
IE60725B1 (en) 1994-08-10
GB2219940A (en) 1989-12-28
IE892047L (en) 1989-12-24
SK278823B6 (sk) 1998-03-04
IT8948116A0 (it) 1989-06-22
PT90962A (pt) 1989-12-29
AU3674489A (en) 1990-01-04
SE502285C2 (sv) 1995-09-25
CH679276A5 (no) 1992-01-31
CA1329130C (en) 1994-05-03
AT396426B (de) 1993-09-27
HK33192A (en) 1992-05-15
SE8902288L (sv) 1989-12-25
BE1005691A4 (fr) 1993-12-21
FR2633181B1 (fr) 1992-01-10
CZ403891A3 (en) 1993-08-11
DE3920626C2 (de) 1994-12-22
LU87541A1 (fr) 1990-02-28
DE3920626A1 (de) 1989-12-28
CZ280886B6 (cs) 1996-04-17
IL90731A0 (en) 1990-01-18
NZ229698A (en) 1991-05-28
DK314089A (da) 1989-12-25
SA90100095B1 (ar) 1999-06-30
KR910000100A (ko) 1991-01-29
CY1637A (en) 1992-11-06
GB2219940B (en) 1992-01-02
PH26018A (en) 1992-01-29

Similar Documents

Publication Publication Date Title
US5102665A (en) Pharmaceutical compositions
US5593685A (en) Ranitidine compositions
JPH08175976A (ja) 発泡性カップル含有のヒスタミンｈ２−拮抗剤発泡性組成物
US5468504A (en) Effervescent pharmaceutical compositions
US20040022866A1 (en) Pharmaceutical compositions with antibiotic activity
US5728401A (en) Effervescent ranitidine formulations
MXPA01010953A (es) Solucion oral de prucalopride.
EP0563094B1 (en) Pharmaceutical compositions
JP4195218B2 (ja) 弱アルカリで安定化される薬剤を含む医薬用液剤
EP0574624B1 (en) Pharmaceutical compositions
KR20000048829A (ko) 액체 알렌드로네이트 제형

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed